Entero Healthcare Solutions Ltd. Net Assets
Entero Healthcare Solutions Ltd. net assets. Based on the latest financial reports, Entero Healthcare Solutions Ltd. (ENTERO) has net assets worth Rs17.53 Billion INR (≈ $189.53 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs36.00 Billion ≈ $389.35 Million USD) and total liabilities (Rs18.48 Billion ≈ $199.82 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Entero Healthcare Solutions Ltd. growing its equity to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs17.53 Billion |
| % of Total Assets | 48.68% |
| Annual Growth Rate | 26.67% |
| 5-Year Change | 211.17% |
| 10-Year Change | N/A |
| Growth Volatility | 56.81 |
Net Assets of Entero Healthcare Solutions Ltd. (2019–2025)
Net assets of Entero Healthcare Solutions Ltd. from 2019 to 2025. This chart illustrates how Entero Healthcare Solutions Ltd.'s net assets have evolved over time, based on quarterly financial data. See ENTERO net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for Entero Healthcare Solutions Ltd. (2019–2025)
The table below shows the annual net assets of Entero Healthcare Solutions Ltd. from 2019 to 2025. For live market cap and overall valuation, see ENTERO market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | Rs17.53 Billion ≈ $189.53 Million |
-1.01% |
| 2024-09-30 | Rs17.70 Billion ≈ $191.46 Million |
+7.86% |
| 2023-09-30 | Rs16.41 Billion ≈ $177.51 Million |
+161.47% |
| 2022-09-30 | Rs6.28 Billion ≈ $67.89 Million |
+11.46% |
| 2021-09-30 | Rs5.63 Billion ≈ $60.91 Million |
+15.64% |
| 2020-09-30 | Rs4.87 Billion ≈ $52.67 Million |
+14.82% |
| 2019-09-30 | Rs4.24 Billion ≈ $45.88 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Entero Healthcare Solutions Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 16129228300.0% over the analyzed period, indicating profitable operations and earnings retention.
Entero Healthcare Solutions Ltd. Net Assets Breakdown (September 2025)
Entero Healthcare Solutions Ltd. net assets breakdown by equity component as of September 2025.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs435.11 Million | 2.58% |
| Other Components | Rs16.45 Billion | 97.42% |
| Total Equity | Rs16.89 Billion | 100.00% |
Entero Healthcare Solutions Ltd. Competitors by Market Cap
The table below lists competitors of Entero Healthcare Solutions Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wuxi Online Offline Communication Information Technology Co. Ltd.
SHE:300959
|
$741.49 Million |
|
Hite Jinro
KO:000080
|
$741.57 Million |
|
Nanjing Doron Technology Corp
SHG:603528
|
$741.69 Million |
|
United Overseas Australia Ltd
AU:UOS
|
$741.92 Million |
|
Himalaya Shipping Ltd
OL:HSHP
|
$741.25 Million |
|
Apacer Technology Inc
TW:8271
|
$741.16 Million |
|
JC Finance & Tax Interconnect Holdings Ltd
SHE:002530
|
$741.14 Million |
|
Shenzhen Sunrise New Energy Co Ltd
SHE:002256
|
$741.11 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Entero Healthcare Solutions Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 17,241,450,000 to 16,886,100,000, a change of -355,350,000 (-2.1%).
- Net income of 1,150,420,000 contributed positively to equity growth.
- New share issuances of 2,600,000 increased equity.
- Other comprehensive income increased equity by 113,340,000.
- Other factors decreased equity by 1,621,710,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs1.15 Billion | +6.81% |
| Share Issuances | Rs2.60 Million | +0.02% |
| Other Comprehensive Income | Rs113.34 Million | +0.67% |
| Other Changes | Rs-1.62 Billion | -9.6% |
| Total Change | Rs- | -2.06% |
Book Value vs Market Value Analysis
This analysis compares Entero Healthcare Solutions Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.07x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 16.21x to 4.07x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-09-30 | Rs97.17 | Rs1575.20 | x |
| 2020-09-30 | Rs111.58 | Rs1575.20 | x |
| 2021-09-30 | Rs128.98 | Rs1575.20 | x |
| 2022-09-30 | Rs143.21 | Rs1575.20 | x |
| 2023-09-30 | Rs452.87 | Rs1575.20 | x |
| 2024-09-30 | Rs395.83 | Rs1575.20 | x |
| 2025-09-30 | Rs387.50 | Rs1575.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Entero Healthcare Solutions Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.81%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.75%
- • Asset Turnover: 1.83x
- • Equity Multiplier: 2.13x
- Recent ROE (6.81%) is above the historical average (0.65%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.22% | 0.07% | 1.80x | 1.77x | Rs-413.25 Million |
| 2020 | -3.20% | -0.88% | 2.13x | 1.72x | Rs-640.74 Million |
| 2021 | -5.33% | -1.19% | 2.23x | 2.01x | Rs-860.24 Million |
| 2022 | -1.86% | -0.35% | 2.35x | 2.25x | Rs-738.52 Million |
| 2023 | 2.39% | 1.00% | 1.67x | 1.43x | Rs-1.25 Billion |
| 2024 | 5.50% | 1.86% | 1.89x | 1.57x | Rs-775.95 Million |
| 2025 | 6.81% | 1.75% | 1.83x | 2.13x | Rs-538.19 Million |
Industry Comparison
This section compares Entero Healthcare Solutions Ltd.'s net assets metrics with peer companies in the Medical Distribution industry.
No peer company data available for comparison.
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more